Personalis introduces the first test to combine an enhanced clinical exome with genome-wide structural variant detection
Personalis, Inc., the leading provider of advanced medical exome and genome sequencing and interpretation services, announced today the closing of a $22 million Series B financing...
Key genome interpretation technology developed by Dr. Butte’s lab is being commercialized by Personalis, Inc., under exclusive license.
Services for researchers engaging in case-control, family-based, or proband-only genome studies of disease and pharmacogenomics
Personalis announced today that it has successfully completed IlluminaCSPro™ certification for sequencing on HiSeq and MiSeq...
Personalis today announced the appointment of Michael Fitzpatrick as Vice President Worldwide Sales. Mr. Fitzpatrick brings substantial experience in sales and sales operations in the life science industry...
Personalis Awarded Contract from VA Million Veteran Program – Whole Genome Sequencing and Data Analysis for Over 1,000 Individuals
The US Department of Veterans Affairs (VA) has awarded its first contract for whole genome DNA sequencing and data analysis to Personalis, Inc...
Personalis Introduces Genome Services for Research – High Accuracy Sequencing and Interpretation of Human Genomes
Services for researchers engaging in case-control, family-based, or proband-only genome studies of disease, pharmacogenomics, and cancer